- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01422044
Risk Prediction in Aortic Stenosis (PREDICT-AS)
Risk Prediction in Aortic Stenosis by Cardiac Autonomic Function
Study Overview
Status
Conditions
Detailed Description
Autonomic function will be assessed by presence of severe autonomic failure (defined by combination of abnormal heart rate turbulence and deceleration capacity).
Autonomic function will also be assessed by respiration and repolarization abnormalities.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Tübingen, Germany, 72076
- Medizinische Klinik Iii
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aortic valve area ≤1.5 qcm or mean aortic gradient ≥25mmHg
Exclusion Criteria:
- life expectancy <1 year due to non-cardiac causes
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Total mortality
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular mortality
Time Frame: 2 years
|
2 years
|
|
|
Combination of cardiovascular mortality and cardiac adverse events
Time Frame: 2 years
|
2 years
|
|
|
Correlation of presence of autonomic dysfunction with severity of aortic stenosis
Time Frame: at time of cardiac catheterization, which will be performed at an expected average of 3 days after hospital admission
|
It will be assessed whether patients with cardiac autonomic dysfunction have more severe aortic stenosis. Autonomic dysfunction will assumed to be present when patients suffer from "severe autonomic failure" (i.e. combination of abnormal Heart Rate Turbulence and Deceleration Capacity). Severity of aortic stenosis will be assessed by clinical (symptoms, NYHA class), hemodynamic (mean aortic gradient, aortic valve area) and biochemical (Nt-BNP, high sensitive troponins) markers. |
at time of cardiac catheterization, which will be performed at an expected average of 3 days after hospital admission
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 402/2009BO2-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Stenosis
-
National Institute of Cardiology, Warsaw, PolandThe Institute of Bioorganic Chemistry, Polish Academy of SciencesRecruitingAortic Stenosis | Low-gradient Aortic StenosisPoland
-
MiRusRecruitingAortic Stenosis | Symptomatic Severe Native Aortic StenosisUnited States
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
Edwards LifesciencesCompletedAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Azienda Ospedaliera "Sant'Andrea"University of Bologna; Politecnico di Milano; Centro Cardiologico Monzino; I.R.C...RecruitingAortic Stenosis | Calcific Aortic Valve Disease | Chronic Coronary Syndrome | Calcific Aortic StenosisItaly
-
Abbott Medical DevicesCompletedSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
Hospices Civils de LyonCompleted
-
Edwards LifesciencesRecruitingAortic Valve Stenosis | Aortic Stenosis, CalcificUnited States, Australia, Switzerland, Canada, Japan, Netherlands
-
University of AlbertaNot yet recruitingAortic Stenosis | Severe Aortic StenosisCanada
-
Medtronic CardiovascularCompleted